SCHEDULE: Deerfield Funds Amend Credit Agreement with Acutus Medical, Initiate Restructuring

Deerfield Funds and Acutus Medical have amended their credit agreement to facilitate restructuring, including the termination of warrants and registration rights, and the issuance of contingent value rights.

Summary

• Deerfield Funds and Acutus Medical have amended their credit agreement to facilitate restructuring and wind down initiatives.
• The amendment includes the termination of warrants held by Deerfield Funds to purchase Acutus Medical common stock at various prices.
• A warrant termination fee of $250,000 will be paid to Deerfield Funds.
• Registration rights for Deerfield Funds will also be terminated.
• Deerfield Funds will receive contingent value rights, potentially entitling them to cash payments up to $300,000 or 5% of the value available to equity holders upon certain conditions.
• The effectiveness of the amendment is conditional on the filing of a Form 15 with the SEC to terminate the registration of the company's securities.

Sentiment

Score: 3

Explanation: The document indicates a significant restructuring effort, which is generally a negative sign for a company's financial health and future prospects. The termination of warrants and registration rights further suggests a lack of confidence in the company's future growth.

Positives

• The restructuring plan provides a clear path forward for Acutus Medical.
• The termination of warrants simplifies the company's capital structure.
• The contingent value rights offer a potential upside for Deerfield Funds.

Negatives

• The restructuring suggests potential financial difficulties for Acutus Medical.
• The termination of warrants indicates a reduced expectation of future growth.
• The contingent value rights are dependent on uncertain future events.

Risks

• The restructuring may not be successful in improving Acutus Medical's financial position.
• The contingent value rights may not result in any significant payment to Deerfield Funds.
• The termination of registration may reduce the liquidity of Acutus Medical's stock.

Future Outlook

The document outlines a restructuring plan for Acutus Medical, with the effectiveness of the plan dependent on certain conditions being met, including the filing of a Form 15 with the SEC.

Industry Context

This announcement reflects a significant restructuring effort, which is not uncommon for companies facing financial challenges in the medical device industry. It suggests a strategic shift to manage debt and potentially wind down operations.

Comparison to Industry Standards

• Restructuring and debt management are common strategies for companies in the medical device sector facing financial difficulties.
• The termination of warrants and registration rights is a typical step in a restructuring process.
• Contingent value rights are sometimes used in restructuring to provide potential future value to creditors or investors.

Stakeholder Impact

• Shareholders may experience a decrease in the value of their holdings due to the restructuring.
• Employees may face uncertainty regarding their job security.
• Creditors may be impacted by the restructuring and potential wind down of the company.

Next Steps

• Acutus Medical needs to file a Form 15 with the SEC to terminate the registration of its securities.
• The company needs to pay the $250,000 warrant termination fee to Deerfield Funds.
• The company needs to satisfy the conditions for the contingent value rights to be triggered.

Key Dates

Keywords

Acutus Medical, Deerfield Funds, Restructuring, Credit Agreement, Warrant Termination, Contingent Value Rights, Registration Rights, SEC Filing